Drugmakers urged to set eyes on overseas markets

Published: 2009-05-04 06:59:00

Updated: 2009-05-04 06:59:00

Korean pharmaceutical firms will have to going all-out to make inroads into three big markets – North America, Europe and Japan – as the domestic market shows clear signs of reaching saturation point.

The nation's rivals, such as Green Cross Corporation, Yuhan Corporation, Hanmi Pharm and Daew...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK